Your browser doesn't support javascript.
loading
The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial.
Yu, Jie; Sweeting, Arianne N; Gianacas, Chris; Houston, Lauren; Lee, Vivian; Fletcher, Robert A; Perkovic, Vlado; Li, Qiang; Neuen, Brendon L; Berwanger, Otavio; Heerspink, Hiddo J L; de Zeeuw, Dick; Arnott, Clare.
Afiliación
  • Yu J; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Sweeting AN; Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Gianacas C; Department of Cardiology, Peking University Third Hospital, Beijing, China.
  • Houston L; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Lee V; The Charles Perkins Centre, University of Sydney, Sydney, Australia.
  • Fletcher RA; Sydney Medical School, University of Sydney, Sydney, Australia.
  • Perkovic V; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Li Q; School of Population Health, University of New South Wales, Sydney, Australia.
  • Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Berwanger O; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Heerspink HJL; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • de Zeeuw D; Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Arnott C; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
Diabetes Obes Metab ; 25(12): 3724-3735, 2023 12.
Article en En | MEDLINE | ID: mdl-37671609
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Infarto del Miocardio Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Infarto del Miocardio Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Australia